Month: March 2024

Fourth Quarter Comparable Sales Declined (3.6)%: a +440 Basis Point Increase vs. (8.0%) Third Quarter 2023 Fourth Quarter Diluted GAAP EPS of $2.21; Grew 12.2% over Last Year Company Opened Seven New Stores in Fourth Quarter; 14 New Stores in 2023 Quarterly Dividend Increased by 22% KATY, Texas, March 21, 2024 (GLOBE NEWSWIRE) — Academy Sports and Outdoors, Inc. (Nasdaq: ASO) (“Academy” or the “Company”) today announced its financial results for the fourth quarter and fiscal year ended February 3, 2024. Fourth quarter and fiscal year 2023 included 14 and 53 weeks respectively, compared to 13 and 52 weeks in fourth quarter and fiscal 2022. “I am proud of the progress we have made and the resiliency that the team has shown, as we have navigated through many challenges over the past year. We have been...

AUSTIN, Texas, March 21, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that management will present a corporate overview at the MedInvest Biotech & Pharma Investor Conference taking place in New York City on April 3-4, 2024. Management will be available for one-on-one meetings with investors who are registered for the conference.Presentation Details:Date: Wednesday, April 3, 2024Time: 4:20 pm ESTWebcast: Recording of the presentation will be available after the event on Aspira’s IR websiteRegistration: Click HERE to register and attend the conference   About MedInvest Biotech & Pharma Investor ConferenceThis two-day conference...

Top-line Results from the NEXUS Phase 2 Clinical Trial of NX-13 for Ulcerative Colitis Planned for Q4 2024 Sufficient Cash to Fund Planned Operations into mid-2025 NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP) (“Landos” or “the Company”), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today provided a business update and reported financial results for the fourth quarter and the full year ended December 31, 2023. “We were focused in 2023 on advancing the NX-13 clinical program and establishing Landos as a leader in targeting immunometabolic pathways and developing novel and first-in-class, oral therapies for autoimmune diseases,” said Gregory Oakes, President and CEO of Landos. “We continue to advance the NEXUS Phase 2 study of...

Aktia Bank Plc Stock Exchange Release 21 March 2024 at 2.00 p.m. Correction to Aktia Bank Plc:s Pillar III Report The Excel appendix to Aktia Bank Plc’s Pillar III Report, published on 13 March 2024 at the same time with Aktia’s annual report for 2023, had some incorrect figures on tab ”Table 6.1.2”, concerning Aktia’s interest rate position. The following corrections have been made to column a, ”Changes of the economic value of equity”, ”Current period”:Parallel up, corrected value -50,4 (incorrect value -45,5) Parallel down, 105,3 (96,2) Steepener, 73,1 (34,3) Flattener, -47,4 (-47,1) Short rates up, -67,3 (-64,8) Short rates down, 69,1 (40,6)The corrected version of the appendix is attached to this release. Aktia Bank Plc Further information: Oscar Taimitarha, Director, Investor Relations, tel. +358 40 562 2315 Distribution:...

NEW CANAAN, Conn., March 21, 2024 (GLOBE NEWSWIRE) — NewLake Capital Partners, Inc. (OTCQX: NLCP) (“The Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, announced today that management is scheduled to participate in the following April 2024 investor conferences. LD Micro Invitational XIVDates: April 8-9, 2024Location: Sofitel New YorkPresentation Day and Time: April 9 at 12:30 p.m. ETPresentation Location: Track 4 – MontmartreWebcast: https://ldinv14.sequireevents.com/ Benzinga Cannabis Capital Conference Dates: April 16-17, 2024Location: The Diplomat Beach Resort, Hollywood, FloridaPanel Day and Time: Tuesday, April 16 at 1:00 p.m. ETPanel: The Cost of Capital and Timing Strategies, moderated by Anthony Coniglio, CEO, Newlake CapitalPanel Location: Stage 2Webcast: https://www.benzinga.com/events/cannabis-conference/ To...

Luxembourg – 21 March 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) will publish its first quarter 2024 results for the period ended 31 March 2024 on Thursday 25 April 2024 at 08:00 CET. A conference call and simultaneous webcast for the investment community will be held on Thursday 25 April 2024 at 13:00 CET. From 08:00 CET the results announcement and the presentation to be reviewed during the conference call and webcast will be available on the Subsea7 website: www.Subsea7.com Conference call registration:Call:                 https://register.vevent.com/register/BI2a40990619354ae5ac59087faaa9cff6Webcast:            https://edge.media-server.com/mmc/p/sir64zas/ *******************************************************************************Subsea7 creates sustainable value by delivering the offshore energy transition solutions the...

Partnering with leading semiconductor companies building out their U.S. footprint due to the CHIPS and Science Act of 2022 NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility services, infrastructure solutions, and transportation management, is playing a vital role as the semiconductor manufacturing industry grows domestic capacity across the U.S., bolstered by the CHIPS and Science Act of 2022. Through unmatched industry expertise and comprehensive end-to-end solutions, ABM is enabling leading semiconductor companies to focus on their product, while ABM delivers all ancillary services, increasing operational efficiency and optimizing uptime. ABM’s specialized semiconductor offerings include the Super Clean Program, a process to maximize efficiency and meet strict project timelines while...